Patent directory · USPTO A61K / A61P
Browse patents
Browse 30,257 pharma-relevant patents (US A61K/A61P) linked to tracked companies, drugs, and pipeline programs.
Quick answer
NovaPharmaNews indexes 30,257 US pharmaceutical patents from USPTO PatentsView (CPC A61K/A61P), cross-linked to company assignees, drug INN profiles, and pipeline programs. Search by patent number, applicant, title, or CPC code — or use facet hubs for expiring patents, assignees, and therapeutic areas.
Patent results
-
US 10912746
Methods and compositions for treating conditions associated with an abnormal inflammatory response
granted -
US 10912771
Methods for the administration of certain VMAT2 inhibitors
granted -
US 10912770
Targeting AMP deaminase 2 for ameliorating craving for sugar and other substances
granted -
US 10912797
Tumor infiltrating lymphocytes and methods of therapy
granted -
US 10913957
Genetically modified MSC and therapeutic methods
granted -
US 10913785
Anti-human papillomavirus 16 E6 T cell receptors
granted -
US 10912783
Formulations for solubilizing hormones
granted -
US 10913709
STAT3 inhibitor formulation
granted -
US 10912779
Quinazolines and azaquinazolines as dual inhibitors of RAS/RAF/MEK/ERK and PI3K/AKT/PTEN/mTOR pathways
granted -
US 10912767
Anthracycline prodrugs and methods of making and using the same
granted -
US 10912776
Methods of treating cancer
granted -
US 10913753
Thienopyridine carboxamides as ubiquitin-specific protease inhibitors
granted -
US 10912741
Prevention of liver cancer with safranal-based formulations
granted -
US 10912764
Salinosporamides and methods of use thereof
granted -
US 10912754
Methods and compositions for treating excessive sleepiness
granted -
US 10912751
Fixed dose combinations and formulations comprising ETC1002 and ezetimibe and methods of treating or reducing the risk of cardiovascular disease
granted -
US 10912860
Controllable self-annealing microgel particles for biomedical applications
granted -
US 10913950
TMPRSS6 iRNA compositions and methods of use thereof
granted -
US 10913948
RNA interference in dermal and fibrotic indications
granted -
US 10913947
Antisense oligomers for treatment of conditions and diseases
granted -
US 10913946
RNA modulating oligonucleotides with improved characteristics for the treatment of Duchenne and Becker muscular dystrophy
granted -
US 10913790
Compositions of, and methods for, alpha-1 anti trypsin Fc fusion molecules
granted -
US 10913888
Nanotube mediation of degradative chemicals for oil-field application
granted -
US 10913798
Modulators of ROR1-ROR2 binding
granted
Frequently asked questions
What patents are included in this directory?
We index 30,257 published US pharma-relevant patents filtered to CPC classes A61K and A61P, with assignee links to our company directory where a match exists.
How do I search for a patent?
Use the search box to match patent number, title, applicant name, or CPC classification (e.g. A61K). For cross-entity queries spanning news and drugs, use the global search.
How is this different from the patent intelligence dashboard?
The dashboard at /patents highlights expirations, recent grants, and assignee rankings. Browse is the full paginated directory with search — best for looking up a specific filing or applicant portfolio slice.